4//SEC Filing
Duncan Barbara Gayle 4
Accession 0000950170-24-076400
CIK 0001593899other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 6:12 PM ET
Size
7.9 KB
Accession
0000950170-24-076400
Insider Transaction Report
Form 4
Duncan Barbara Gayle
Director
Transactions
- Award
Restricted Stock Units
2024-06-21+29,600→ 29,600 total→ Common Stock (29,600 underlying) - Award
Stock Option (Right to Buy)
2024-06-21+41,200→ 41,200 totalExercise: $3.44Exp: 2034-06-20→ Common Stock (41,200 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
- [F3]The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 21, 2024, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.
Documents
Issuer
Atea Pharmaceuticals, Inc.
CIK 0001593899
Entity typeother
Related Parties
1- filerCIK 0001353128
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 6:12 PM ET
- Size
- 7.9 KB